PMC:7454258 / 108499-109740
Annnotations
LitCovid-PD-FMA-UBERON
Id | Subject | Object | Predicate | Lexical cue | fma_id |
---|---|---|---|---|---|
T13835 | 1005-1016 | Body_part | denotes | fatty acids | http://purl.org/sig/ont/fma/fma82738 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T48074 | 3-7 | http://purl.obolibrary.org/obo/CLO_0001185 | denotes | 2018 |
T90567 | 77-87 | http://purl.obolibrary.org/obo/CLO_0001658 | denotes | activities |
T40040 | 96-97 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T45665 | 276-282 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | labels |
T67162 | 343-348 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | Label |
T24539 | 358-366 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | Labeling |
T45300 | 436-437 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T60711 | 458-463 | http://purl.obolibrary.org/obo/CLO_0007225 | denotes | label |
T72438 | 514-515 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
T70450 | 1201-1202 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T53735 | 377-383 | Chemical | denotes | sodium | http://purl.obolibrary.org/obo/CHEBI_26708 |
T16345 | 458-463 | Chemical | denotes | label | http://purl.obolibrary.org/obo/CHEBI_35209 |
T16460 | 904-907 | Chemical | denotes | DRI | http://purl.obolibrary.org/obo/CHEBI_51039 |
T29923 | 997-1016 | Chemical | denotes | omega-3 fatty acids | http://purl.obolibrary.org/obo/CHEBI_25681 |
T46686 | 1005-1016 | Chemical | denotes | fatty acids | http://purl.obolibrary.org/obo/CHEBI_35366 |
T49597 | 1011-1016 | Chemical | denotes | acids | http://purl.obolibrary.org/obo/CHEBI_37527 |
LitCovid-PD-GO-BP
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T64080 | 581-592 | http://purl.obolibrary.org/obo/GO_0065007 | denotes | regulations |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
583 | 377-383 | Chemical | denotes | sodium | MESH:D012964 |
584 | 997-1016 | Chemical | denotes | omega-3 fatty acids | MESH:D015525 |
585 | 154-170 | Disease | denotes | chronic diseases | MESH:D002908 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T567 | 0-177 | Sentence | denotes | In 2018, FDA announced their Nutrition Innovation Strategy that outlined key activities to take a “fresh look” at what can be done to reduce diet-related chronic diseases (210). |
T568 | 178-484 | Sentence | denotes | Key elements included the following: modernizing claims such as “healthy,” modernizing ingredient labels and standards of identity, implementing the Nutrition Facts Label and Menu Labeling, reducing sodium, and expanding nutrition education (e.g., launching a new Nutrition Facts label education campaign). |
T569 | 485-682 | Sentence | denotes | For example, FDA agreed with a petition that its definition of “healthy,” central for marketing regulations, was scientifically outdated and inconsistent with the DGAs and advancing research (211). |
T570 | 683-871 | Sentence | denotes | Insufficient scientific evidence on dietary supplement contents, health effects, and potential risks limits the FDA's ability to provide oversight for this $40 billon/y industry (212–214). |
T571 | 872-1065 | Sentence | denotes | As another example, there is no DRI or listing on Nutrition Facts for many compounds that appear relevant for health such as omega-3 fatty acids, phenolics, and other phytonutrients (212, 215). |
T572 | 1066-1241 | Sentence | denotes | Further, many processing methods and additives banned in the European Union are permitted in the US, based on insufficient science for a definitive determination by FDA (216). |